Szolar D H, Preidler K, Ebner F, Kammerhuber F, Horn S, Ratschek M, Ranner G, Petritsch P, Horina J H
Department of Radiology, Karl-Franzens University, Graz, Austria.
Magn Reson Imaging. 1997;15(7):727-35. doi: 10.1016/s0730-725x(97)00088-x.
Graft dysfunction is a common occurrence during the first weeks following renal transplantation. The current study was designed to evaluate the potential of renal magnetic resonance (MR) perfusion imaging to differentiate acute allograft rejection (AAR) from acute tubular necrosis (ATN) during the post-transplant period. Twenty-three consecutive patients with clinically suspected ATN and/or AAR and eight consecutive control patients (asymptomatic, serum creatinine concentration < 1.5 mg/dL) underwent MR perfusion imaging of the renal allograft within 64 days after transplantation. Histopathology was obtained in all cases with clinical suspicion of ATN or AAR. Sixty sequential fast gradient-recalled-echo MR images were acquired in each patient after intravenous administration of gadolinium-DTPA (0.1 mmol/kg). Histopathology revealed 6 patients with pure AAR, 4 patients with a combination of AAR and ATN, 12 patients with ATN and 1 patient with normal findings. Kidney graft recipients with normal renal function showed a moderate increase in signal intensity (SI) of the renal cortex and medulla after administration of contrast agent followed by an immediate and short decrease in SI of the medulla (biphasic medullary enhancement pattern). The increase in cortical SI of patients with AAR was significantly smaller (61 +/- 4% increase above baseline) than that measured in normal allografts (136 +/- 9% increase above baseline) (p < 0.05) and patients with ATN (129 +/- 3% increase above baseline) (p < .05). Patients with ATN had a slightly delayed and diminished cortical enhancement and an uniphasic and lesser medullary enhancement pattern compared to that observed in normal allografts (p < 0.05). A close correlation (r = 0.72) was found between serum creatinine concentration levels and changes in SI. Thus, MR imaging results and histopathology were in agreement in 22 of 23 patients (96%). MR perfusion imaging of renal allografts can be used to noninvasively differentiate ATN from AAR during the post-transplant period, and may also be helpful in cases were covert AAR is superimposing ATN during a phase of anuria. Patients with ATN can be separated from normals in the majority of cases as reflected by an uniphasic medullary enhancement pattern.
移植肾功能障碍是肾移植后最初几周内的常见情况。本研究旨在评估肾磁共振(MR)灌注成像在移植后期间区分急性同种异体移植排斥反应(AAR)和急性肾小管坏死(ATN)的潜力。23例临床怀疑为ATN和/或AAR的连续患者以及8例连续的对照患者(无症状,血清肌酐浓度<1.5mg/dL)在移植后64天内接受了同种异体肾的MR灌注成像检查。所有临床怀疑为ATN或AAR的病例均进行了组织病理学检查。每位患者在静脉注射钆喷酸葡胺(0.1mmol/kg)后采集60幅连续的快速梯度回波MR图像。组织病理学显示,6例为单纯AAR,4例为AAR与ATN合并,12例为ATN,1例结果正常。肾功能正常的肾移植受者在注射造影剂后肾皮质和髓质的信号强度(SI)有中度增加,随后髓质SI立即出现短暂下降(双相髓质强化模式)。AAR患者皮质SI的增加(比基线增加61±4%)明显小于正常同种异体移植(比基线增加136±9%)(p<0.05)和ATN患者(比基线增加129±3%)(p<0.05)。与正常同种异体移植相比,ATN患者的皮质强化略有延迟且减弱,髓质强化模式为单相且较弱(p<0.05)。血清肌酐浓度水平与SI变化之间存在密切相关性(r=0.72)。因此,23例患者中有22例(96%)的MR成像结果与组织病理学结果一致。肾同种异体移植的MR灌注成像可用于在移植后期间无创区分ATN和AAR,在无尿期隐性AAR叠加在ATN的情况下可能也有帮助。大多数情况下,ATN患者可通过单相髓质强化模式与正常人区分开来。